Poster Oral Presentation 6

[PO-056] Safety and Efficacy of Intralesional Administration of TH-SC01 Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Perianal Fistula in Crohn's Disease: Phase 1 and 2 Clinical Trials

*Zixuan He¹, Zhaoshen Li¹, Yu Bai¹, Bin Jiang², Shaohua Huangfu², Qiu Zhao³, Xiujun Liao⁴, Faming Zhang⁵, Xiang Gao⁶, Heng Zhang⁶, Jian Tang⁶, Lungen Lu⁷, Qian Cao⁸, Xiaowei Liu⁹, Fangyu Wang¹⁰, Juan Wei¹⁰, Zhijun Cao¹¹, Zhe Cui¹¹, Xinmei Zhao¹², Shenglong Li¹², Yandi Liu¹³ (1. Changhai Hospital, Naval Medical University, Shanghai, China, 2. Nanjing Hospital of Chinese Medicine, Nanjing, China, 3. Zhongnan Hospital of Wuhan University, Wuhan, China, 4. The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China, 5. The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China, 6. The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 7. Shanghai General Hospital, Shanghai, China, 8. Sir Run Run Shaw Hospital,Hangzhou, China, 9. Xiangya Hospital of Central South University, Changsha, China, 10. Jinling Hospital, Medical School of Nanjing University, Nanjing, China, 11. Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai, China, 12. Nanfang Hospital, Southern Medical University, Guangzhou, China, 13. Tianjin Union Medical Center, Nankai University, Tianjin, China)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.